P27蛋白在肝细胞肝癌组织中的表达及意义

被引:3
作者
王科
王学浩
张峰
机构
[1] 南京医科大学第一附属医院肝胆外科
[2] 南京医科大学第一附属医院肝胆外科 南京
[3] 南京
关键词
肝细胞肝癌; P27蛋白;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
目的 探计 P2 7蛋白在肝细胞肝癌组织中的表达及其与临床病理学特征关系。方法 采用免疫组织化学 S-P染色法检测 3 3例肝细胞癌组织中 P2 7蛋白表达 ,并分析其与临床病理学特征的关系进行分析。结果 P2 7蛋白的表达在进展期肝癌组织中显著降低 ,P2 7阳性表达率在高 TNM分期 (3 /15 ) ,中低分化 (6/2 0 ) ,有癌栓 (3 /14 ) ,直径大于 3 cm(9/12 )的肝癌组织中显著低于 TNM分期 (13 /18) ,高分化 (10 /13 ) ,无癌栓 (13 /19) ,直径小于 3 cm(7/12 )的肝癌组织。P值分别为 0 .0 0 5、0 .0 13、0 .0 13、0 .0 3 2。结论  p2 7蛋白表达量的减少和肝细胞肝癌的恶生程度及侵袭性密切相关 ,可能成为一个新的预后指标
引用
收藏
页码:71 / 72
页数:2
相关论文
共 9 条
[1]  
Increased proteasom-dependent degradation of cyclin -dependant kinase inhibitor p27 in aggressive colorectal carcinoma. Loda M,Cnker B,Tam SW,et al. Nature Medicine . 1997
[2]  
Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Thomas GV,Szigeti K,Murphy M,et al. American Journal of Pathology . 1998
[3]  
Cyclins and cancer Ⅱ: cyclin-D and CDK inhibitors come of age. Hunter T,Pines J. Cell . 1994
[4]  
Increased proteasoma-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Loda M,Cukor B,Tam SW,et al. Nature Medicine . 1997
[5]  
Cloning of p27 kipl , a cyclin-dependent kinase inhibitor and a potential mediator of extracelluar antimitogenic signals. Polyak K,lee MH,Erdijument -Bromage H,et al. Cell . 1994
[6]  
p27 kipl in human lung cancers: differential changes in small cell and non-small cell carcinoma. Yatabe Y,Masuda A,Koshikawa T,et al. Cancer Research . 1998
[7]  
High level expression of p27 ( kipl ) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27( kipl ) and degree of malignancy in human breast and colorectal cancers. Fredersdorf S,Burns J,Milne AM,et al. Proceedings of the National Academy of Sciences of the United States of America . 1997
[8]  
The cell cycle inhibitor p27 is an independent prognostic marker in small invasive breast carcinoma. Tan P,Cady B,Wanner M,et al. Cancer Research . 1997
[9]  
Prognostic role of the cyclindependent kinase inhibitor p27 in non-small cell lung cancer. Esposito V,Baldi A,Deluca,et al. Cancer Research . 1997